Literature DB >> 30623290

Organ-sparing procedures in GU cancer: part 1-organ-sparing procedures in renal and adrenal tumors: a systematic review.

Raouf Seyam1, Mahmoud I Khalil2, Mohamed H Kamel2, Waleed M Altaweel1, Rodney Davis2, Nabil K Bissada3.   

Abstract

PURPOSE: Organ-sparing surgery (OSS) for the kidney and adrenals has emerged as the need for preservation of function is paramount in patients with poor functional reserve. As reports increasingly showed that oncological outcomes were equivalent to radical excision, elective OSS became a viable alternative in patients with otherwise normal reserve. In this review, we summarize the current knowledge of OSS for adrenal and renal tumors.
MATERIALS AND METHODS: PubMed, Web of Science and Cochrane Library Central Search were searched for recently published articles up to December 2017. The following keywords were used; "partial adrenalectomy", "adrenal sparing", "partial nephrectomy", "nephron sparing", "kidney/renal cancer".
RESULTS: Partial adrenalectomy became an attractive alternative to total adrenalectomy avoiding adrenal insufficiency. Both minimally invasive surgery and ablative techniques were increasingly reported for adrenal OSS with adequate residual adrenal function and excellent oncological outcome. Radical nephrectomy remained for many years as the gold standard of treatment for organ-confined renal cell carcinoma. As the need to reduce the impact on renal function, more conservative approaches were utilized. Soon, the non-inferiority of nephron-sparing surgery to that of radical excision became evident and elective partial nephrectomy was gaining ground as the standard of care for small renal masses in patients with normal contralateral kidneys.
CONCLUSIONS: Herein, we present a comprehensive review of the current status of OSS in renal and adrenal tumors.

Entities:  

Keywords:  Nephron sparing; Organ sparing; Partial adrenalectomy; Partial nephrectomy

Mesh:

Year:  2019        PMID: 30623290     DOI: 10.1007/s11255-018-02070-5

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  164 in total

1.  A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma.

Authors:  Hendrik Van Poppel; Luigi Da Pozzo; Walter Albrecht; Vsevolod Matveev; Aldo Bono; Andrzej Borkowski; Marc Colombel; Laurence Klotz; Eila Skinner; Thomas Keane; Sandrine Marreaud; Sandra Collette; Richard Sylvester
Journal:  Eur Urol       Date:  2010-12-22       Impact factor: 20.096

2.  Distinguishing benign from malignant adrenal masses: multi-detector row CT protocol with 10-minute delay.

Authors:  Michael A Blake; Mannudeep K Kalra; Ann T Sweeney; Brian C Lucey; Michael M Maher; Dushyant V Sahani; Elkan F Halpern; Peter R Mueller; Peter F Hahn; Giles W Boland
Journal:  Radiology       Date:  2005-12-21       Impact factor: 11.105

3.  Prognostic significance of preoperative kidney volume for predicting renal function in renal cell carcinoma patients receiving a radical or partial nephrectomy.

Authors:  Hwang Gyun Jeon; In Hyuck Gong; Jin Ho Hwang; Don Kyung Choi; Seung Ryeol Lee; Dong Soo Park
Journal:  BJU Int       Date:  2011-08-25       Impact factor: 5.588

4.  Adrenal incidentaloma: an overview of clinical and epidemiological data from the National Italian Study Group.

Authors:  A Angeli; G Osella; A Alì; M Terzolo
Journal:  Horm Res       Date:  1997

5.  Nephrectomy induced chronic renal insufficiency is associated with increased risk of cardiovascular death and death from any cause in patients with localized cT1b renal masses.

Authors:  Christopher J Weight; Benjamin T Larson; Amr F Fergany; Tianming Gao; Brian R Lane; Steven C Campbell; Jihad H Kaouk; Eric A Klein; Andrew C Novick
Journal:  J Urol       Date:  2010-02-19       Impact factor: 7.450

6.  Parenchymal Volumetric Assessment as a Predictive Tool to Determine Renal Function Benefit of Nephron-Sparing Surgery Compared with Radical Nephrectomy.

Authors:  Michael A Liss; Robert DeConde; Dominique Caovan; Joseph Hofler; Michael Gabe; Kerrin L Palazzi; Nishant D Patel; Hak J Lee; Trey Ideker; Hendrik Van Poppel; David Karow; Michael Aertsen; Giovanna Casola; Ithaar H Derweesh
Journal:  J Endourol       Date:  2015-09-25       Impact factor: 2.942

7.  Is there a role for partial nephrectomy in patients with metastatic renal cell carcinoma?

Authors:  Nicholas J Hellenthal; Ahmed M Mansour; Matthew H Hayn; Thomas Schwaab
Journal:  Urol Oncol       Date:  2011-03-10       Impact factor: 3.498

8.  Laparoscopic and open partial nephrectomy: a matched-pair comparison of 200 patients.

Authors:  Martin Marszalek; Herbert Meixl; Marko Polajnar; Michael Rauchenwald; Klaus Jeschke; Stephan Madersbacher
Journal:  Eur Urol       Date:  2009-02-20       Impact factor: 20.096

9.  Renal cell carcinoma: radiofrequency ablation with a multiple-electrode switching system--a phase II clinical study.

Authors:  Haruyuki Takaki; Atsuhiro Nakatsuka; Junji Uraki; Takashi Yamanaka; Masashi Fujimori; Takaaki Hasegawa; Kiminobu Arima; Yoshiki Sugimura; Koichiro Yamakado
Journal:  Radiology       Date:  2013-01-11       Impact factor: 11.105

10.  Is preservation of the adrenal vein mandatory in laparoscopic adrenal-sparing surgery?

Authors:  N Roukounakis; S Dimas; I Kafetzis; S Bethanis; N Gatsulis; H Kostas; V Kyriakou; S Michas
Journal:  JSLS       Date:  2007 Apr-Jun       Impact factor: 2.172

View more
  2 in total

1.  Experience in the application of laparoscopic anatomical adrenalectomy via the renal cortex surface monolayer.

Authors:  Tao Ma; Wen-Zeng Yang; Zhenyu Cui; Chunli Zhao
Journal:  Pak J Med Sci       Date:  2020 May-Jun       Impact factor: 1.088

Review 2.  Tailored Approach in Adrenal Surgery: Retroperitoneoscopic Partial Adrenalectomy.

Authors:  Pier Francesco Alesina; Polina Knyazeva; Jakob Hinrichs; Martin K Walz
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-28       Impact factor: 5.555

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.